A G Protein-coupled Receptor for UDP-glucose*

Uridine 5′-diphosphoglucose (UDP-glucose) has a well established biochemical role as a glycosyl donor in the enzymatic biosynthesis of carbohydrates. It is less well known that UDP-glucose may possess pharmacological activity, suggesting that a receptor for this molecule may exist. Here, we show that UDP-glucose, and some closely related molecules, potently activate the orphan G protein-coupled receptor KIAA0001 heterologously expressed in yeast or mammalian cells. Nucleotides known to activate P2Y receptors were inactive, indicating the distinctly novel pharmacology of this receptor. The receptor is expressed in a wide variety of human tissues, including many regions of the brain. These data suggest that some sugar-nucleotides may serve important physiological roles as extracellular signaling molecules in addition to their familiar role in intermediary metabolism.

[1]  L. Yip,et al.  Effects of uridine diphosphoglucose (UDPG) infusion on 5-phosphoribosyl pyrophosphate (PRPP) levels of mouse tissues. , 1987, Biochemical pharmacology.

[2]  R. Mulligan,et al.  Two dominant-acting selectable markers for gene transfer studies in mammalian cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Thorner,et al.  The STE2 gene product is the ligand-binding component of the alpha-factor receptor of Saccharomyces cerevisiae. , 1988, The Journal of biological chemistry.

[4]  E. Kieff,et al.  Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors , 1993, Journal of virology.

[5]  M. Simon,et al.  Gα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C (*) , 1995, The Journal of Biological Chemistry.

[6]  Paul J. Harrison,et al.  Structure‐activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion , 1995, British journal of pharmacology.

[7]  J. Broach,et al.  Yeast alpha mating factor structure-activity relationship derived from genetically selected peptide agonists and antagonists of Ste2p , 1996, Molecular and cellular biology.

[8]  H. Herzog,et al.  Intron 17 of the human retinoblastoma susceptibility gene encodes an actively transcribed G protein-coupled receptor gene. , 1996, Genome research.

[9]  M. Spedding,et al.  X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. , 1996, Pharmacological reviews.

[10]  D. Middlemiss,et al.  GR127935 acts as a partial agonist at recombinant human 5-HT1Dα and 5-HT1Dβ receptors , 1996 .

[11]  G. Burnstock.  The past, present and future of purine nucleotides as signalling molecules , 1997, Neuropharmacology.

[12]  T. K. Harden,et al.  Direct Demonstration of Mechanically Induced Release of Cellular UTP and Its Implication for Uridine Nucleotide Receptor Activation* , 1997, The Journal of Biological Chemistry.

[13]  T. Kendall Harden,et al.  An examination of deoxyadenosine 5′(α‐thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor , 1997, British journal of pharmacology.

[14]  R. Duman,et al.  The isolation and characterization of a novel G protein-coupled receptor regulated by immunologic challenge , 1997, Brain Research.

[15]  M. Colbert,et al.  A genetic selection for isolating cDNAs encoding secreted proteins. , 1997, Gene.

[16]  R. Nicholas,et al.  HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors , 1997, Neuropharmacology.

[17]  J. Broach,et al.  Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast , 1998, Nature Biotechnology.

[18]  Jilly F. Evans,et al.  Receptor for motilin identified in the human gastrointestinal system. , 1999, Science.

[19]  J. Chambers,et al.  Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1 , 1999, Nature.

[20]  J. Chambers,et al.  Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. , 1999, Molecular pharmacology.

[21]  H. Sarau,et al.  Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 , 1999, Nature.

[22]  H. Heng,et al.  Discovery of three novel orphan G-protein-coupled receptors. , 1999, Genomics.